Early onset or syndromic epilepsy
Gene: FGFR3
The rating of this gene has been updated to Green following NHS Genomic Medicine Service approval.Created: 11 Oct 2023, 11:59 a.m. | Last Modified: 11 Oct 2023, 11:59 a.m.
Panel Version: 4.110
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Associated with relevant phenotype in OMIM and as definitive Gen2Phen gene for hypochondroplasia. The variant NM_000142.5(FGFR3):c.1620C>A (p.Asn540Lys) has been reported in at least six unrelated cases of hypochondroplasia (OMIM:146000), in which the patients also display epileptic seizures (PMIDs:12794698; 16222682;17621485 ;2463028; 23165795; 27485793). Biallelic FGFR3 variants have been also been reported in a novel phenotype of achondroplasia, which also includes seizures (PMID: 30160829). Migrating neonatal seizures were also reported in a case of Muenke syndrome (OMIM:602849), carrying the variant: NM_000142.5(FGFR3):c.749C>G (p.Pro250Arg)(PMID: 28551036).Created: 16 Feb 2023, 4:36 p.m. | Last Modified: 16 Feb 2023, 4:36 p.m.
Panel Version: 3.55
Comment on list classification: There is enough evidence for this gene to be rated GREEN at the next major review.Created: 16 Feb 2023, 4:12 p.m. | Last Modified: 16 Feb 2023, 4:12 p.m.
Panel Version: 3.55
Comment on phenotypes: Isolated seizures have also been reported in cases with: Muenke syndrome, OMIM:602849;Muenke syndrome, MONDO:0011274;SADDAN, OMIM:616482;severe achondroplasia-developmental delay-acanthosis nigricans syndrome, MONDO:0014658Created: 16 Feb 2023, 3:41 p.m. | Last Modified: 16 Feb 2023, 3:41 p.m.
Panel Version: 3.53
Paper by Okazaki et al 2017. States HCH patients with the N540K variant are reported to have medial temporal lobe dysgenesis and epilepsy. Not mentioned on OMIM. Other papers 2017/2018 suggesting link with HCH and epilepsy. Not enough evidence to add to panel and due to the presence of short stature, they will hopefully have been diagnosed on the HCH/ACH panel.Created: 6 Aug 2019, 8:31 p.m. | Last Modified: 6 Aug 2019, 8:31 p.m.
Panel Version: 1.188
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Achondroplasia, 100800; Bladder cancer, somatic, 109800; CATSHL syndrome, 610474; Cervical cancer, somatic, 603956; Colorectal cancer, somatic, 114500; Crouzon syndrome with acanthosis nigricans, 612247; Hypochondroplasia, 146000; LADD syndrome, 149730; Muenke syndrome, 602849; Nevus, epidermal, somatic, 162900; SADDAN, 616482; Spermatocytic seminoma, somatic, 273300; Thanatophoric dysplasia, type I, 187600; Thanatophoric dysplasia, type II, 187601;
Publications
As discussed with members of the GMS Neurology Specialist Test Group on the Webex call Thursday 8th August 2019 for Clinical Indication R59 Early onset or syndromic epilepsy: Agreed that this gene should be rated Amber because the Craniosynostosis panel is more appropriate for testing. Demoted from Green to Amber.Created: 15 Aug 2019, 10:06 a.m. | Last Modified: 15 Aug 2019, 10:06 a.m.
Panel Version: 1.228
Review and rating collated by Tracy Lester (Oxford Medical Genetics Laboratories Oxford University Hospitals NHS Foundation Trust, 2019_02_06) on behalf of Wessex and West Midlands GLH for GMS Neurology specialist test group, for Clinical Indication R59 'Early onset or syndromic epilepsy'. Review contributors: John Taylor and Helen Lord. Suggested gene rating: Amber.Created: 6 Aug 2019, 8:38 p.m. | Last Modified: 6 Aug 2019, 8:38 p.m.
Panel Version: 1.189
PMID:28551036: Okubo et al., 2017 report a 3 year old Japanese boy with Muenke syndrome who had repetitive apneic spell followed by focal status epilepticus in the early infancy. Thee long-term seizure prognosis was favorable. WES revealed a heterozygous variant in FGFR3: c.749C>G, p250A.Created: 22 Jul 2019, 12:25 p.m. | Last Modified: 22 Jul 2019, 12:25 p.m.
Panel Version: 1.173
Comment on list classification: Changed from Amber to Green. Appropriate phenotypes, sufficient cases, and external review comment all support gene-disease association.Created: 14 Nov 2018, 12:02 p.m.
Comment on phenotypes: added additional relevant phenotype Muenke syndrome Millichap, J.G., 2012. Epilepsy in Muenke Syndrome. Pediatric Neurology Briefs, 26(12), pp.93–93. DOI: http://doi.org/10.15844/pedneurbriefs-26-12-6 : A review of 789 published cases of Muenke syndrome with neurological complications identified epilepsy in 6 cases, with intracranial anomalies in 5. The intracranial anomalies were agenesis of the corpus callosum, hemimegalencephaly, and porencephaly. In the review of 58 patients with Muenke syndrome in the Washington, DC cohort, 7 (12%) had epilepsy and 4 survived neonatal apnea. Patients with Muenke syndrome should be monitored for apnea and seizures.Created: 14 Nov 2018, noon
Comment on publications: Hypochondroplasia and FGFR3 variants are associated with characteristic abnormalities involving bilaterally medial temporal lobe structures, probable hippocampal cortex focal dysplasia, and early onset of focal epilepsy and was first reported PMID: 24630288 (2014). Subsequent cases PMID: 27485793, PMID:23649205, PMID:12794698. In addition, patients with with Muenke syndrome (MS) also show similarities in early-onset temporal lobe-related seizures PMID:23044018, PMID:12794698, PMID:18000976.Created: 14 Nov 2018, 11:54 a.m.
Comment on phenotypes: Added phenotype suggested from expert review that indicate relevance to inclusion on the Genetic Epilepsy Syndromes panel.Created: 14 Nov 2018, 11:25 a.m.
This condition is well documented as being associated with epilepsy. It can be difficult to recognise clinically, particularly in infancy and therefore we consider this gene merits as much inclusion in an Epilepsy panel as other syndromic diagnoses (e.g. EFTUD2 etc).Created: 22 Jan 2020, 9:23 a.m. | Last Modified: 22 Jan 2020, 9:23 a.m.
Panel Version: 2.0
There are reports of seizures in hypochondroplasia (likely related to temporal lobe abnormalities).Created: 13 Aug 2018, 12:40 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Hypochondroplasia, MIM#146000
Publications
Variants in this GENE are reported as part of current diagnostic practice
Tag Q1_23_promote_green was removed from gene: FGFR3.
Source Expert Review Green was added to FGFR3. Rating Changed from Amber List (moderate evidence) to Green List (high evidence)
Gene: fgfr3 has been classified as Amber List (Moderate Evidence).
Tag Q1_23_promote_green tag was added to gene: FGFR3.
Publications for gene: FGFR3 were set to 30160829; 28551036; 27485793; 23649205; 24630288; 17621485; 16222682; 12794698; 23044018; 12794698; 18000976; http://doi.org/10.15844/pedneurbriefs-26-12-6; http://www.ashg.org/genetics/ashg07s/f20570.htm; https://jicna.org/index.php/journal/article/view/100
Phenotypes for gene: FGFR3 were changed from Hypochondroplasia, OMIM:146000; hypochondroplasia, MONDO:0007793; Muenke syndrome, OMIM:602849; Muenke syndrome, MONDO:0011274; SADDAN, OMIM:616482; severe achondroplasia-developmental delay-acanthosis nigricans syndrome, MONDO:0014658 to Hypochondroplasia, OMIM:146000; hypochondroplasia, MONDO:0007793
Publications for gene: FGFR3 were set to 28551036; 27485793; 23649205; 24630288; 17621485; 16222682; 12794698; 23044018; 12794698; 18000976; http://doi.org/10.15844/pedneurbriefs-26-12-6; http://www.ashg.org/genetics/ashg07s/f20570.htm; https://jicna.org/index.php/journal/article/view/100
Phenotypes for gene: FGFR3 were changed from Hypochondroplasia, 146000; Focal Epilepsy; Muenke syndrome, 602849; Epilepsy to Hypochondroplasia, OMIM:146000; hypochondroplasia, MONDO:0007793; Muenke syndrome, OMIM:602849; Muenke syndrome, MONDO:0011274; SADDAN, OMIM:616482; severe achondroplasia-developmental delay-acanthosis nigricans syndrome, MONDO:0014658
Gene: fgfr3 has been classified as Amber List (Moderate Evidence).
Gene: fgfr3 has been classified as Amber List (Moderate Evidence).
Gene: fgfr3 has been classified as Amber List (Moderate Evidence).
Source Wessex and West Midlands GLH was added to FGFR3.
Source NHS GMS was added to FGFR3.
Publications for gene: FGFR3 were set to 27485793; 23649205; 24630288; 17621485; 16222682; 12794698; 23044018; 12794698; 18000976; http://doi.org/10.15844/pedneurbriefs-26-12-6; http://www.ashg.org/genetics/ashg07s/f20570.htm; https://jicna.org/index.php/journal/article/view/100
Zornitza Stark: There are reports of seizures
Publications for gene: FGFR3 were set to 27485793; 23649205; 24630288; 17621485; 16222682; 12794698; 23044018; 12794698; 18000976; http://doi.org/10.15844/pedneurbriefs-26-12-6; http://www.ashg.org/genetics/ashg07s/f20570.htm
Publications for gene: FGFR3 were set to 27485793; 23649205; 24630288; 17621485; 16222682; 12794698; 23044018; 12794698; 18000976; http://doi.org/10.15844/pedneurbriefs-26-12-6
Phenotypes for gene: FGFR3 were changed from Hypochondroplasia, 146000; Focal Epilepsy; Muenke syndrome 602849, Epilepsy to Hypochondroplasia, 146000; Focal Epilepsy; Muenke syndrome, 602849; Epilepsy
Gene: fgfr3 has been classified as Green List (High Evidence).
Gene: fgfr3 has been classified as Green List (High Evidence).
Publications for gene: FGFR3 were set to 27485793; 23649205; 24630288; 17621485; 16222682; 12794698; 23044018; 12794698; 18000976
Phenotypes for gene: FGFR3 were changed from Hypochondroplasia, 146000; Focal epilepsy to Hypochondroplasia, 146000; Focal Epilepsy; Muenke syndrome 602849, Epilepsy
Mode of inheritance for gene: FGFR3 was changed from to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Publications for gene: FGFR3 were set to
Phenotypes for gene: FGFR3 were changed from to Hypochondroplasia, 146000; Focal epilepsy
Expert Review Amber was added to FGFR3. Panel: Genetic Epilepsy Syndromes
FGFR3 was added to Genetic Epilepsy Syndromes panel. Sources: Victorian Clinical Genetics Services
FGFR3 was created by Sarah Leigh